CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3
0.600
GeneticVariation
disease
UNIPROT
Mutations in γ adducin are associated with inherited cerebral palsy.
23836506
2013
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3
0.600
Biomarker
disease
GENOMICS_ENGLAND
Mutations in γ adducin are associated with inherited cerebral palsy.
23836506
2013
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3
0.600
Biomarker
disease
CTD_human
Bipolar Disorder
0.400
Biomarker
disease
CTD_human
Genome-wide association study identifies 30 loci associated with bipolar disorder.
31043756
2019
Bipolar Disorder
0.400
GeneticVariation
disease
GWASCAT
Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder.
28072414
2017
Depression, Bipolar
0.300
Biomarker
disease
CTD_human
Genome-wide association study identifies 30 loci associated with bipolar disorder.
31043756
2019
Manic Disorder
0.300
Biomarker
disease
CTD_human
Genome-wide association study identifies 30 loci associated with bipolar disorder.
31043756
2019
×
CUI:
C0338831
Disease:
Manic
Manic
0.300
Biomarker
disease
CTD_human
Genome-wide association study identifies 30 loci associated with bipolar disorder.
31043756
2019
Liver Cirrhosis, Experimental
0.300
Biomarker
disease
CTD_human
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
25380136
2014
Cerebral Palsy, Spastic Quadriplegic, 1
0.300
GermlineCausalMutation
disease
ORPHANET
Mutations in γ adducin are associated with inherited cerebral palsy.
23836506
2013
Encephalopathy, Toxic
0.300
Biomarker
disease
CTD_human
Blood gene expression markers to detect and distinguish target organ toxicity.
19784758
2010
Toxic Encephalitis
0.300
Biomarker
disease
CTD_human
Blood gene expression markers to detect and distinguish target organ toxicity.
19784758
2010
Neurotoxicity Syndromes
0.300
Biomarker
group
CTD_human
Blood gene expression markers to detect and distinguish target organ toxicity.
19784758
2010
Brain Ischemia
0.300
Biomarker
disease
CTD_human
Tamoxifen neuroprotection in cerebral ischemia involves attenuation of kinase activation and superoxide production and potentiation of mitochondrial superoxide dismutase.
17901229
2008
Cerebral Ischemia
0.300
Biomarker
disease
CTD_human
Tamoxifen neuroprotection in cerebral ischemia involves attenuation of kinase activation and superoxide production and potentiation of mitochondrial superoxide dismutase.
17901229
2008
Hypertensive disease
0.200
Biomarker
group
RGD
A hypertension -linked decrease of gamma-adducin was confirmed by demonstrating a decrease in gamma-adducin expression in hypothalamic/brainstem neuronal cultures from prehypertensive SH rats.
12364392
2002
Cerebral Palsy
0.110
GeneticVariation
disease
BEFREE
Mutations in γ adducin are associated with inherited cerebral palsy .
23836506
2013
Cerebral Palsy
0.110
CausalMutation
disease
CLINVAR
Eosinophil count procedure
0.100
GeneticVariation
phenotype
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
Adolescent idiopathic scoliosis
0.100
GeneticVariation
disease
GWASCAT
The coexistence of copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) at a locus can result in distorted calculations of the significance in associating SNPs to disease.
30019117
2018
SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3
0.100
GeneticVariation
disease
GWASCAT
The coexistence of copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) at a locus can result in distorted calculations of the significance in associating SNPs to disease.
30019117
2018
Deglutition Disorders
0.100
Biomarker
group
HPO
Exotropia
0.100
Biomarker
disease
HPO
Little's Disease
0.100
Biomarker
disease
HPO
Microcephaly
0.100
Biomarker
disease
HPO